Skip to content

New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder

On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years. 

Read More

Back To Top